Fitness, Health and Nutrition

Heart & Circulation

Heart & Circulation

  • Blood Pressure That Resists Treatment Got Its Own Playbook From Cardiologists

    CATEGORY: HEART & CIRCULATION

    The American College of Cardiology has published a step-by-step playbook for blood pressure that won’t come down, formally called resistant hypertension: readings still at 130/80 mm Hg or higher despite three medicines at the highest tolerated doses, or pressure that needs four drugs to stay controlled.1 The 2026 expert consensus pathway, posted online in the Journal of the American College of Cardiology, is written for clinicians. It’s also a clear window into how stubborn blood pressure gets untangled.

    Step One Is Proving It’s Real

    Much of what looks resistant isn’t. The pathway’s first moves target impostors. Some are mundane. A reading taken minutes after rushing in from the parking lot can run high. So can pressure measured with a too-small cuff, or in a doctor’s office when nerves kick in, the white-coat effect. The document leans on out-of-office measurements, home monitors and 24-hour wearable cuffs, to confirm the numbers are real, and it asks clinicians to rule out missed doses and interfering substances before escalating. One caution stands out: cuffless gadgets that estimate blood pressure from a watch or ring aren’t validated enough yet for clinical decisions.1

    Then Escalate on a Schedule, Not a Shrug

    Once resistance is confirmed, the pathway lays out a sequence summarized by the acronym RESIST: rule out pseudoresistance, exclude interfering substances, support lifestyle changes, intensify and optimize medications, screen for secondary causes such as hormonal disorders, and refer to a specialist when needed. It pushes single-pill combinations to make regimens easier to actually take, team-based care for complex patients, and timely escalation whenever readings stay above threshold rather than watchful drift. For some patients it discusses renal denervation, a catheter procedure that quiets overactive nerves around the kidney arteries. None of this replaces the 2025 blood pressure guideline. It exists to make that guideline happen in real clinics, where nonadherence and inertia do their quiet damage.1

    Key Takeaways

    • Resistant hypertension means 130/80 mm Hg or higher on three optimized medicines, or control that requires four; confirming it starts with accurate, out-of-office measurement.
    • The ACC pathway orders the response: verify adherence, fix measurement, intensify treatment, screen for secondary causes, and consider devices or referral, escalating on blood pressure thresholds rather than waiting.

    References

    1. Davis LL, Yang E, Blyler CA, et al. Optimizing Blood Pressure Care in Patients With Resistant Hypertension: 2026 ACC Expert Consensus Decision Pathway: A Report of the American College of Cardiology Solution Set Oversight Committee. Journal of the American College of Cardiology. 2026; j.jacc.2026.08.028. link
    For educational purposes only — not medical advice. Consult your clinician before acting on this content.

    Found this useful? Please share it!

    Link copied!

    Stay up to date! Subscribe to our FREE weekly newsletter.

    Follow us:

    More from Heart & Circulation!

  • A New Kind of Pill Lowered Blood Pressure That Standard Drugs Couldn’t Control

    You can take two or three blood pressure medicines every day and still watch the monitor read high. For people stuck in that spot, a new pill called baxdrostat lowered systolic pressure, the top number, by nearly 10 points more… Read More →

  • A Monthly Injection for Severe Triglycerides Made Pancreatitis Attacks Far Rarer

    Can pulling triglycerides down keep people out of the hospital with pancreatitis? That question drove two identical trials in 1,063 adults with severely elevated triglycerides. The answer was yes. Monthly injections of olezarsen cut attacks of acute pancreatitis by 85%… Read More →

  • Blood Pressure Pills Worked the Same at Bedtime as in the Morning

    Switching blood pressure pills to bedtime changed nothing the BedMed trial could measure. Over a median of 4.6 years, 2.3 of every 100 bedtime dosers per year died or went to hospital with a stroke, heart attack or heart failure.… Read More →

  • Deeper Cholesterol Lowering Cut First Heart Attacks and Strokes in High-Risk Adults

    Nearly everything proven about the powerful cholesterol-lowering injections called PCSK9 inhibitors came from people who'd already survived a heart attack or stroke. The VESALIUS-CV trial asked whether evolocumab could protect people before that first event, and it did: over a… Read More →

  • Older Adults Who Added Dapagliflozin After a Valve Replacement Had Fewer Heart Failure Setbacks

    A new heart valve at 82 is meant to be a fresh start. Too often, heart failure circles back within the year. In a Spanish trial of 1,222 patients who had just had an aortic valve replaced through a leg… Read More →

  • Adults at Heart Risk Saw LDL Cholesterol Fall Sharply on a New Daily Pill

    For a decade, the most powerful cholesterol drugs have come with a needle attached. If statins didn't get your LDL low enough, the next step up meant injections. That barrier just fell. In a 52-week trial of 2,909 adults with… Read More →

  • Aficamten Improved Symptoms in a Form of Heart Disease That Had No Approved Treatment

    A year and a half ago, this story looked closed. Mavacamten, the first drug of its kind, had just failed in the nonobstructive form of hypertrophic cardiomyopathy, missing both of its main goals in a trial of 580 patients. Its… Read More →

  • Bedtime Blood Pressure Pills Matched Morning Doses for Heart Outcomes

    Does the clock matter when you take your blood pressure pill? A Canadian trial that followed 3,357 adults for a median of 4.6 years says it doesn't: people who took their usual medications at bedtime had heart attacks, strokes, heart… Read More →

  • For Heart Failure With a Stiffened Heart, Finerenone Cut Worsening Episodes

    A daily pill called finerenone reduced worsening heart-failure episodes and cardiovascular deaths, taken together, by 16% in people whose hearts pump normally but have grown stiff. In absolute terms, that meant 14.9 such events for every 100 patients each year… Read More →